Mouse gene targeting reveals an essential role of mTOR in hematopoietic stem cell engraftment and hematopoiesis

Haematologica

Volumn 98, Issue 9, 2013, Pages 1353-1358

  Guo, Fukun ^a,b   Zhang, Shuangmin ^b   Grogg, Matthew ^b   Cancelas, Jose A ^b   Varney, Melinda E ^b   Starczynowski, Daniel T ^b,c   Du, Wei ^b   Yang, Jun Qi ^b   Liu, Wei ^b   Thomas, George ^c   Kozma, Sara ^c   Pang, Qishen ^b   Zheng, Yi ^b  

^a JINAN UNIVERSITY   (China)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD150 ANTIGEN; CD34 ANTIGEN; CD48 ANTIGEN; FIBRINOGEN RECEPTOR; HEMOGLOBIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN BCL XL;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; ENGRAFTMENT; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE TARGETING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; MOUSE; NONHUMAN; PANCYTOPENIA; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; GENE TARGETING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MICE; MICE, KNOCKOUT; MICE, SCID; TOR SERINE-THREONINE KINASES;

EID: 84883639503     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.080424     Document Type: Article

References (20)

1. Gan B, DePinho RA. mTORC1 signaling governs hematopoietic stem cell quiescence. Cell Cycle. 2009;8(7):1003-6.
2. Foster KG, Fingar DC. Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J Biol Chem. 2010;285(19):14071-7.
3. Proud CG. The multifaceted role of mTOR in cellular stress responses. DNA Repair (Amst). 2004;3(8-9):927-34.
4. Raslova H, Baccini V, Loussaief L, Comba B, Larghero J, Debili N, et al. Mammalian target of rapamycin (mTOR) regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation. Blood. 2006;107(6):2303-10.
5. Sathaliyawala T, O'Gorman WE, Greter M, Bogunovic M, Konjufca V, Hou ZE, et al. Mammalian target of rapamycin controls dendritic cell development downstream of Flt3 ligand signaling. Immunity. 2010;33(4):597-606.
6. Martelli AM, Evangelisti C, Chiarini F, Grimaldi C, Cappellini A, Ognibene A, et al. The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogensis. Biochim Biophys Acta. 2010;1803(9):991-1002.
7. Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT, et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature. 2006;441(7092):518-22.
8. Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, Liu Y, et al. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med. 2008;205(10):2397-408.
9. Gangloff YG, Mueller M, Dann SG, Svoboda P, Sticker M, Spetz JF, et al. Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol. 2004;24(21):9508-16.
10. Delgoffe GM, Kole T P, Zheng Y, Zarek PE, Matthews KL, Xiao B, et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity. 2009;30(6):832-44.
11. Risson V, Mazelin L, Roceri M, Sanchez H, Moncollin V, Corneloup C, et al. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J Cell Biol. 2009;187(6):859-74.
12. Um SH, D'Alessio D, Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab. 2006;3(6):393-402.
13. Rohrabaugh SL, Campbell TB, Hangoc G, Broxmeyer HE. Ex vivo rapamycin treatment of human cord blood CD34+ cells enhances their engraftment of NSG mice. Blood Cell Mol Dis. 2011;46(4):318-20.
14. Kalaitzidis D, Sykes SM, Wang Z, Punt N, Tang Y, Ragu C, et al. mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis. Cell Stem Cell. 2012;11(3):429-39.
15. Hoshii T, Tadokoro Y, Naka K, Ooshio T, Muraguchi T, Sugiyama N, et al. mTORC1 is essential for leukemia propagation but not stem cell self-renewal. J Clin Invest. 2012;122(6): 2114-29.
16. Tang F, Wu Q, Ikenoue T, Guan KL, Liu Y, Zheng P. A critical role for rictor in T lymphopoiesis. J Immunol. 2012;189(4):1850-7.
17. Lee K, Nam KT, Cho SH, Gudapati P, Hwang Y, Park DS, et al. Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia. J Exp Med. 2012;209(4):713-28.
18. Magee JA, Ikenoue T, Nakada D, Lee JY, Guan KL, Morrison SJ. Temporal Changes in PTEN and mTORC2 Regulation of Hematopoietic Stem Cell Self-Renewal and Leukemia Suppression. Cell Stem Cell. 2012;11(3):415-28.
19. Guo F, Li J, Du W, Zhang S, O'Connor M, Thomas G, Kozma S, et al. mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells. Leukemia. 2013 Mar 29.
20. Patursky-Polischuk I, Stolovich-Rain M, Hausner-Hanochi M, Kasir J, Cybulski N, Avruch J, et al. The TSC-mTOR pathway mediates translational activation of TOP mRNAs by insulin largely in a raptor-or rictor-independent manner. Mol Cell Biol. 2009;29(3):640-9.